Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales1 4211 4001 5091 5971 7291 891
Operating income (EBITDA)273280315357411458
Operating profit (EBIT)183190224259302355
Pre-Tax Profit (EBT)------
Net income12795,6144188222268
P/E ratio30,446,344,433,128,223,4
EPS ( $ )1,751,301,912,522,953,55
Dividend per Share ( $ )0,410,46-0,540,580,62
Yield0,77%0,76%-0,64%0,69%0,74%
Reference price ( $ )53.2460.2284.8383.2483.2483.24
Announcement Date02/19/2015
12:00pm
02/18/2016
12:00pm
02/16/2017
12:17pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt--25,6---
Finance---61,091,0112
Operating income (EBITDA)273280315357411458
Leverage
(Debt/EBITDA)
--0,08x---
Capital Expenditure-132170155155155
Book Value Per Share (BVPS)-14,2 $-16,8 $18,4 $20,7 $
Cash Flow per Share2,51 $2,88 $2,93 $3,81 $4,29 $5,14 $
Announcement Date02/19/2015
12:00pm
02/18/2016
12:00pm
02/16/2017
12:17pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 6 092 M$ -
Entreprise Value (EV) 6 031 M$ 6 001 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 33,1x 28,2x
Capitalization / Revenue 3,81x 3,52x
EV / Revenue 3,78x 3,47x
EV / EBITDA 16,9x 14,6x
Yield (DPS / Price) 0,64% 0,69%
Price to book (Price / BVPS) 4,95x 4,53x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 16,2% 17,5%
operating Leverage (Delta EBIT / Delta Sales) 2,72x 2,02x
Net Margin (Net Profit / Revenue) 11,8% 12,8%
ROA (Net Profit / Asset) 9,90% 11,3%
ROE (Net Profit / Equities) 15,0% 16,1%
Rate of Dividend 21,3% 19,5%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   9,70% 8,97%
Cash Flow / Sales 17,4% 18,1%
Capital Intensity (Assets / Sales) 1,19x 1,13x
Financial Leverage (Net Debt / EBITDA) -0,17x -0,22x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend